Boothbay Fund Management’s Aptose Biosciences, Inc. APTO Stock Holding History

Boothbay Fund Management’s Portfolio APTO Stock Details APTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-23	Closed	-$14K	–	2826
2022 Q1	$14K	Hold	23	–	–	﹤0.01%	2231
2021 Q4	$14K	Hold	23	–	–	﹤0.01%	1803
2021 Q3	$23K	Sell	23 -4	-15%	-$5K	﹤0.01%	1848
2021 Q2	$40K	Hold	27	–	–	﹤0.01%	1774
2021 Q1	$73K	Buy	+27	New	+$53.5K	﹤0.01%	1487
2020 Q1	–	Sell	-383	Closed	-$978K	–	1137
2019 Q4	$978K	Buy	383 +278	+265%	+$362K	0.09%	323
2019 Q3	$98K	Buy	105 +39	+59%	+$44.4K	0.01%	704
2019 Q2	$77K	Buy	+66	New	+$60.7K	0.01%	673

Other funds holding APTO

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return

SMH

Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SPC

Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PAWC

P.A.W. Capital Greenwich, Connecticut $36.7M AUM 6.81% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Boothbay Fund Management's APTO Position: Q2 2022 in Review

Boothbay Fund Management sold out of Aptose Biosciences, Inc. (APTO) in Q2 2022, closing a stake of 23 shares — an estimated $14K sold.

Boothbay Fund Management first reported a position in APTO in Q2 2019 and held it in 8 quarters. The position peaked at $978K in Q4 2019. 48 funds tracked by Wall St. Rank hold APTO as of Q2 2022.

Boothbay Fund Management reported no remaining Aptose Biosciences, Inc. position as of Q2 2022 after selling out during the quarter.
Boothbay Fund Management sold 23 Aptose Biosciences, Inc. shares in Q2 2022, an estimated $14K.
Boothbay Fund Management first reported a position in Aptose Biosciences, Inc. in Q2 2019 and held it in 8 quarters.
Boothbay Fund Management's Aptose Biosciences, Inc. position peaked at $978K in Q4 2019.
48 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q2 2022.

Based on Boothbay Fund Management's 13F filing for Q2 2022, filed 15 Aug 2022.